XORTX Therapeutics (XRTX) Selling, General & Administrative (2020 - 2026)
XORTX Therapeutics (XRTX) reported Selling, General & Administrative of $64,722 for the quarter ended Jun 30, 2026, up 8.8% from $59,495 a year earlier and up 9.1% from the prior quarter.
XORTX Therapeutics (XRTX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, XORTX Therapeutics' Selling, General & Administrative came in at $245,812, down 10.0% year-over-year; for the year ended Dec 31, 2025, it came in at $172,512, down 26.4% from the prior year.
- Selling, General & Administrative has declined for three consecutive years, though with a five-year compound annual growth rate of 89.3% (years ended Dec 2020 to Dec 2025).
- By year, Selling, General & Administrative came in at $234,421 in the year ended Dec 31, 2024 (-15.8%), $278,312 in the year ended Dec 31, 2023 (-38.0%), $448,824 in the year ended Dec 31, 2022 (+220.6%) and $139,983 in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Selling, General & Administrative since the quarter ended Dec 31, 2024.
- Year over year, Selling, General & Administrative gained in four of the last eight quarters, with an average decline of 4.3%.
- The high point for year-over-year Selling, General & Administrative in five years was the quarter ended Jun 30, 2022 (growth of 644.2%); the low point was the quarter ended Mar 31, 2023 (a decline of 50.5%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $59,350 (quarter ended Mar 31, 2026), $60,615 (quarter ended Dec 31, 2025) and $61,125 (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | XORTX Therapeutics | 1.64 Mn | -1.66 Mn | - | 64,722.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64,722.00 |
| Mar 31, 2026 | 59,350.00 |
| Dec 31, 2025 | 60,615.00 |
| Sep 30, 2025 | 61,125.00 |
| Jun 30, 2025 | 59,495.00 |
| Mar 31, 2025 | 59,797.00 |
| Dec 31, 2024 | 72,006.00 |
| Sep 30, 2024 | 81,765.00 |
| Jun 30, 2024 | 92,258.00 |
| Mar 31, 2024 | 55,599.12 |
| Dec 31, 2023 | 68,728.29 |
| Sep 30, 2023 | 67,238.17 |
| Jun 30, 2023 | 67,223.31 |
| Mar 31, 2023 | 75,078.44 |
| Dec 31, 2022 | 64,996.35 |
| Sep 30, 2022 | 89,890.26 |
| Jun 30, 2022 | 96,840.19 |
| Mar 31, 2022 | 151,804.00 |
| Dec 31, 2021 | 91,927.82 |
| Sep 30, 2021 | 3,949.01 |
XORTX Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();